Email updates

Keep up to date with the latest news and content from Arthritis Research & Therapy and BioMed Central.

Commentary

Tumor necrosis factor-α blockade in ankylosing spondylitis: a potent but expensive anti-inflammatory treatment or true disease modification?

Filip Van den Bosch*, Filip De Keyser, Herman Mielants and Eric M Veys

Arthritis Research & Therapy 2005, 7:121-123  doi:10.1186/ar1742

Accesses  

  • Last 30 days: 18 accesses
  • Last 365 days: 302 accesses
  • All time: 2493 accesses